Testosterone (cypionate, enanthate)
Testosterone is a steroid hormone, not a peptide, but it is sold by the same clinics. It is FDA-approved for men with low testosterone tied to a medical condition, it is a controlled substance, and its label changed in 2025 after a large safety trial.
- Legal lane: FDA-approved, prescription only. Schedule III controlled substance.
- Evidence grade: A for its approved use
- Forms: injections into muscle (cypionate, enanthate, undecanoate), gels, patches, pellets and oral capsules
- Approved for: men with low testosterone and an associated medical condition
What it is
Testosterone is the main male sex hormone. The injectable forms, testosterone cypionate and testosterone enanthate, are testosterone attached to a fatty acid so that an injection in oil releases slowly over weeks. Cypionate has been on the US market since the 1950s.
What the evidence shows
The largest safety trial is TRAVERSE, published in 2023. It followed 5,246 men with symptoms of low testosterone and existing or raised heart risk for about 33 months. Major heart events occurred in 7.0% of men on testosterone gel and 7.3% on placebo, so testosterone was no worse than placebo on that measure.
Separate blood pressure monitoring studies, which the FDA required of manufacturers, found that testosterone products raise blood pressure across the class.
The A grade is for the approved use. Use by men whose testosterone is low only because of age is the contested area, covered below.
Legal status
- Approved use: the FDA states that testosterone is approved only for men who lack or have low testosterone together with an associated medical condition. Labels require low morning testosterone measured on at least two separate days before starting.
- Controlled substance: testosterone is in Schedule III under the Anabolic Steroids Control Act.
- February 2025: the FDA required a blood pressure warning on every testosterone product and recommended removing the boxed warning language about heart risk, based on TRAVERSE. It kept the statement that safety and effectiveness in age-related low testosterone have not been established.
- June 18, 2026: HHS requested further class-wide changes: removing that age-related limitation, narrowing the prostate cancer contraindication to metastatic disease, and updating the warnings on enlarged prostate. These were requests, not final label changes, when we checked.
Testosterone is prohibited in sport.
Label dosing
For testosterone cypionate injection, the FDA label gives 50 mg to 400 mg every two to four weeks, injected deep into the gluteal muscle, with the dose and schedule set for the individual. The reference listings give the same range for testosterone enanthate.
Clinics often prescribe other schedules. Those are prescriber decisions, not the label, and we have no single source to report for them. The dose on your prescription is the one to follow.
Safety
- Blood pressure: raised across the class. Since 2025 every testosterone label carries a warning about it.
- Fertility: testosterone can lower sperm production. This matters for anyone planning to father a child.
- Blood clots: labels carry a warning about clots in the veins.
- Prostate: current labels generally advise against use in men with known or suspected prostate cancer.
- Children and partners: gels can transfer to others through skin contact.
- Misuse: doses above the prescribed range carry serious heart, liver and psychiatric risks described in the label's abuse section.
Common questions
Is testosterone a peptide?
No. It is a steroid hormone. It appears here because the same clinics sell it alongside peptides.
Is testosterone a controlled substance?
Yes. It is a Schedule III controlled substance in the US and requires a prescription.
Does testosterone raise heart risk?
In the TRAVERSE trial, major heart events were similar on testosterone and placebo, 7.0% and 7.3%. Testosterone does raise blood pressure, and labels now carry a warning about that.
What is the label dose of testosterone cypionate?
The FDA label gives 50 mg to 400 mg every two to four weeks by injection into muscle, set for the individual.
Ask an AI about this page
Opens the assistant with a question about this page already typed in. You can edit it before sending.
Ask ChatGPTAsk ClaudeAsk Perplexity
These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.
Sources
- FDA: class-wide labeling changes for testosterone products (February 28, 2025)
- FDA label: testosterone cypionate injection (dosage, hypogonadism confirmation, Schedule III)
- Pfizer: Depo-Testosterone dosage and administration
- Urology Times: HHS requests testosterone label updates, with TRAVERSE figures (June 19, 2026)
- Healio: FDA label changes and the retained age-related limitation (March 2025)